SCHEMBL6254428

SCHEMBL6254428

CCOP(=O)(C=Cc1cc(Cl)ccc1O)OCC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 1/20 0.46
ABL1 P00519 1/20 0.46
ABCB1 P08183 1/20 0.46
BCR P11274 1/20 0.46
KMT2A Q03164 7/20 0.41
MEN1 O00255 6/20 0.41
TDP1 Q9NUW8 2/20 0.41
NR1I2 O75469 1/20 0.41
HPGD P15428 3/20 0.40
EGFR P00533 1/20 0.39
POLB P06746 1/20 0.38
TSHR P16473 2/20 0.38
MAPT P10636 5/20 0.36
GAA P10253 3/20 0.36
MAPK1 P28482 2/20 0.36
KDM1A O60341 1/20 0.36
LMNA P02545 1/20 0.36
HSP90AA1 P07900 1/20 0.36
TP53 P04637 2/20 0.36
ALOX15 P16050 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6254422 1.00 ERN1 (0.46) ERN1ABL1ABCB1BCRKMT2A
SCHEMBL8662087 0.75 MAOB (0.42) KMT2AMEN1TDP1NR1I2POLB
SCHEMBL8662084 0.75 MAOB (0.42) KMT2AMEN1TDP1NR1I2POLB
SCHEMBL6254433 0.75 ABL1 (0.41) ERN1ABL1ABCB1BCRKMT2A
SCHEMBL8936166 0.74 POLB (0.42) KMT2ATDP1POLBMAPTGAA
SCHEMBL28283048 0.72 TTR (0.58) ERN1ABL1ABCB1BCRKMT2A
SCHEMBL28283049 0.72 TTR (0.58) ERN1ABL1ABCB1BCRKMT2A
SCHEMBL9121817 0.71 KMT2A (0.33) KMT2AMEN1TDP1NR1I2EGFR
SCHEMBL9122474 0.71 KMT2A (0.33) KMT2AMEN1TDP1NR1I2EGFR
SCHEMBL6253586 0.71 POLB (0.67) ERN1KMT2AMEN1TDP1NR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1572704-A1 PHOSPHORUS-CONTAINING PIPERAZINE DERIVATIVES AS CCR1 ANTAGONISTS Pfizer Products Inc. (US) 2005-09-14 EP disclosed
US-20040127465-A1 Novel phosphorus-containing derivatives PFIZER INC 2004-07-01 US disclosed
WO-2004055031-A1 PHOSPHORUS-CONTAINING PIPERAZINE DERIVATIVES AS CCR1 ANTAGONISTS PFIZER PRODUCTS INC. (US) 2004-07-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040127465-A1 Novel phosphorus-containing derivatives SLC34A2, SLC34A1, SLC20A1 ERN1 1918/4885ABL1 3867/4885ABCB1 484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.